What does Achieve Life Sciences, Inc. do?
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces…
What is Achieve Life Sciences, Inc.'s P/E and P/B ratio?
Achieve Life Sciences, Inc. has a P/E ratio of -3.8 and a P/B ratio of -45.66.
What is Achieve Life Sciences, Inc.'s debt-to-equity ratio?
Achieve Life Sciences, Inc. has a debt-to-equity ratio of 0.69.
How much does Achieve Life Sciences, Inc. owe compared with what it owns?
Achieve Life Sciences, Inc. owes $1.08 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Achieve Life Sciences, Inc.'s Positivity rank?
Achieve Life Sciences, Inc. is ranked #6,676 of 6,774 companies globally and #3,912 of 4,000 in United States on PositoAI, with a Positivity Score of -43,256.
Does Achieve Life Sciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Achieve Life Sciences, Inc..
Where can I read the latest news about Achieve Life Sciences, Inc.?
Recent headlines about Achieve Life Sciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Achieve Life Sciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Achieve Life Sciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.